Replimune (REPL) Total Liabilities (2018 - 2026)

Replimune (REPL) has 9 years of Total Liabilities data on file, last reported at $166.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 22.69% year-over-year to $166.2 million; the trailing twelve-month figure through Mar 2026 stood at $166.2 million (up 22.69% YoY), and the FY2026 full-year result was $166.2 million, up 22.69% from the prior year.
• Total Liabilities advanced to $166.2 million in Q1 2026, from $123.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $166.2 million in Q1 2026 to a low of $49.2 million in Q2 2022.
• A 5-year average of $104.0 million and a median of $111.4 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 86.89% in 2023 and gained 1.48% in 2025, its largest moves.
• Tracing REPL's Total Liabilities over 5 years: stood at $83.2 million in 2022, then soared by 33.88% to $111.4 million in 2023, then advanced by 8.85% to $121.3 million in 2024, then grew by 1.48% to $123.1 million in 2025, then surged by 35.09% to $166.2 million in 2026.
• Business Quant data shows REPL's Total Liabilities at $166.2 million in Q1 2026, $123.1 million in Q4 2025, and $126.1 million in Q3 2025.